Upregulation of Pparγ and Srebp1-mediated de novo lipogenesis has been associated with inflammation, increased proliferation and tumour progression in many types of cancer and thus provides a possible link between HFHSD-induced metabolic signalling, crypt-cell hyperproliferation and increased risk of gastrointestinal cancer43. The gene discussed is SREBF1; the disease is neoplasm.